The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression

Weifeng Liang; Ming Gu; Lingxiang Zhu; Ziqi Yan; Dominik Schenten; Shelby Herrick; Hongmin Li; Subodh Kumar Samrat; Jiapeng Zhu; Yin Chen

doi:10.1038/s41392-023-01418-3

The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression

Weifeng Liang, Ming Gu, Lingxiang Zhu, Ziqi Yan, Dominik Schenten, Shelby Herrick, Hongmin Li, Subodh Kumar Samrat, Jiapeng Zhu, Yin Chen

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Article number	162
Journal	Signal Transduction and Targeted Therapy
Volume	8
Issue number	1
DOIs	https://doi.org/10.1038/s41392-023-01418-3
State	Published - Dec 2023

ASJC Scopus subject areas

Genetics
Cancer Research

Access to Document

10.1038/s41392-023-01418-3

Cite this

@article{cd64e20165e44701a5295cbf1fd03032,

title = "The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression",

author = "Weifeng Liang and Ming Gu and Lingxiang Zhu and Ziqi Yan and Dominik Schenten and Shelby Herrick and Hongmin Li and Samrat, {Subodh Kumar} and Jiapeng Zhu and Yin Chen",

note = "Funding Information: The study was supported partly by NIH grants: AI139439, AI149754, ES027013, ES028889 to YC. HL was supported by NIH grants: AI161845, AI131669, AI140406, AI141178, and AI140726, and by R. Ken and Donna Coit Endowed Chair fund in Drug Discovery. SH was supported by a NIEHS training grant ES025494 (YC).",

year = "2023",

month = dec,

doi = "10.1038/s41392-023-01418-3",

language = "English (US)",

volume = "8",

journal = "Signal Transduction and Targeted Therapy",

issn = "2095-9907",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression

AU - Liang, Weifeng

AU - Gu, Ming

AU - Zhu, Lingxiang

AU - Yan, Ziqi

AU - Schenten, Dominik

AU - Herrick, Shelby

AU - Li, Hongmin

AU - Samrat, Subodh Kumar

AU - Zhu, Jiapeng

AU - Chen, Yin

N1 - Funding Information: The study was supported partly by NIH grants: AI139439, AI149754, ES027013, ES028889 to YC. HL was supported by NIH grants: AI161845, AI131669, AI140406, AI141178, and AI140726, and by R. Ken and Donna Coit Endowed Chair fund in Drug Discovery. SH was supported by a NIEHS training grant ES025494 (YC).

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85152407866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85152407866&partnerID=8YFLogxK

U2 - 10.1038/s41392-023-01418-3

DO - 10.1038/s41392-023-01418-3

M3 - Letter

C2 - 37055405

SN - 2095-9907

VL - 8

JO - Signal Transduction and Targeted Therapy

JF - Signal Transduction and Targeted Therapy

IS - 1

M1 - 162

ER -

The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this